Fentanyl Injectable Syringes Recalled for Lack of Sterility Assurance
Central Admixture Pharmacy Services Inc. is recalling 1,762 fentanyl syringes nationwide due to lack of assurance of sterility. No illnesses or injuries have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable product due to lack of sterility assurance, presenting a significant risk of contamination and infection. No illnesses or injuries have been reported, classifying it as a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Central Admixture Pharmacy Services Inc. is recalling fentanyl in 0.9% sodium chloride, 10 mcg/1 mL, in 3 mL syringes distributed nationwide. The recall affects 1,762 syringes with NDC 71286-2071-7.
The recall is due to a lack of assurance of sterility. Affected lot numbers are 17-275858 (expiration 10/11/2023), 17-275967, and 17-275981 (expiration 10/15/2023).
Healthcare providers and dispensing facilities should identify and quarantine affected syringes. Patients who have received these syringes should contact their healthcare provider. No illnesses or injuries have been reported as of the recall announcement.
The recalled product
- Product
- fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Injectable
- Hazard
- lack-of-sterility
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot: 17-275858
- Exp. 10/11/2023
- 17-275967
- 17-275981
- Exp. 10/15/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27